Terbiderm

Terbinafine

Trade Name:

Terbiderm

Product Code:

SA16912

Active Substance:

Terbinafine ( as Terbinafine hydrochloride x 281.3 mg )

Dosage/Volume:

250 mg

Pharmaceutical Form:

Tablets

Package:

Box x 30

ATC Classification System:

D Dermatological

OTC:

No

RX:

Yes

Product Registration:

Albania

Terbiderm – 250 mg Tablets

Terbiderm 250 mg contains the active substance terbinafine hydrochloride, which is a drug that acts against fungal infections (antifungal).

Terbiderm is indicated in:
• fungal infections of the fingernails and toenails (distal-subungual onychomycosis) caused by dermatophytes; in mixed infections of the nails with distal-subungual type mycosis, an experimental treatment is applied;
• severe, resistant fungal infections of the feet (tinea pedis) and body (tinea corporis and tinea cruris), caused by dermatophytes and that are not adequately treated by topical therapy.

Note:
To confirm the diagnosis, it is recommended to take appropriate skin or nail specimens for laboratory testing (KOH preparation, fungal culture or nail biopsy) before starting treatment with Terbiderm 250 mg. In contrast to locally used terbinafine, Terbiderm is not effective in mycotic infections (candidiasis, pityriasis versicolor) of the skin.

ATC CODE:
D01BA02

Shelf life:
36 months